Distribution and accumulation of liposomal form of doxorubicin in breast cancer cells of MCF-7 line
Aim: To study distribution and accumulation of liposomal form of doxorubicin in human breast cancer cells of MCF-7 line and Dox-resistant subline MCF-7/Dox. Methods: High performance liquid chromatography and laser confocal microscopy were used. Results: It has been shown that conventional form of d...
Saved in:
| Published in: | Experimental Oncology |
|---|---|
| Date: | 2011 |
| Main Authors: | Rusetskaya, N.V., Khariton, N., Yurchenko, O.V., Chekhun, V.F. |
| Format: | Article |
| Language: | English |
| Published: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2011
|
| Subjects: | |
| Online Access: | https://nasplib.isofts.kiev.ua/handle/123456789/138616 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Cite this: | Distribution and accumulation of liposomal form of doxorubicin in breast cancer cells of MCF-7 line / N.V. Rusetskaya, N. Khariton, O.V. Yurchenko, V.F. Chekhun // Experimental Oncology. — 2011. — Т. 33, № 2. — С. 78-82. — Бібліогр.: 22 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of UkraineSimilar Items
Molecular profile and cell cycle in MCF-7 and MCF‑7/Dox cells exposed to conventional and liposomal forms of doxorubicin
by: Rusetskaya, N.V., et al.
Published: (2009)
by: Rusetskaya, N.V., et al.
Published: (2009)
The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
by: Todor, I.N., et al.
Published: (2012)
by: Todor, I.N., et al.
Published: (2012)
Molecular profile and cell cycle in mcf-7 cells resistant to cisplatin and doxorubicin
by: Lukyanova, N.Yu., et al.
Published: (2009)
by: Lukyanova, N.Yu., et al.
Published: (2009)
Correlation of iodine symporter expression in highly and low malignant cell lines of human breast cancer differed in their sensitivity to doxorubicin
by: Lukianova, N.Yu., et al.
Published: (2016)
by: Lukianova, N.Yu., et al.
Published: (2016)
Ultrastructural changes in tumor cells treated with liposomal forms of anticancer drugs
by: Yurchenko, O.V., et al.
Published: (2010)
by: Yurchenko, O.V., et al.
Published: (2010)
Characteristics of homocysteine-induced multidrug resistance of human MCF-7 breast cancer cells and human A2780 ovarian cancer cells
by: Lukyanova, N.Yu.
Published: (2010)
by: Lukyanova, N.Yu.
Published: (2010)
Artemisinin modulating effect on human breast cancer cell lines with different sensitivity to cytostatics
by: Chekhun, V.F., et al.
Published: (2017)
by: Chekhun, V.F., et al.
Published: (2017)
Morphological features of doxorubicin-resistant Walker 256 carcinosarcoma and response of mast cells
by: Boroday, N.V., et al.
Published: (2018)
by: Boroday, N.V., et al.
Published: (2018)
Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
by: Chekhun, S., et al.
Published: (2013)
by: Chekhun, S., et al.
Published: (2013)
Effect of 5-azacytidine on mirna expression in human breast cancer cells with different sensitivity to cytostatics
by: Chekhun, V.F., et al.
Published: (2016)
by: Chekhun, V.F., et al.
Published: (2016)
Lactoferrin expression in breast cancer in relation to biologic properties of tumors and clinical features of disease
by: Naleskina, L.A., et al.
Published: (2016)
by: Naleskina, L.A., et al.
Published: (2016)
Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs
by: Yalovenko, T.M., et al.
Published: (2016)
by: Yalovenko, T.M., et al.
Published: (2016)
Modifying effects of lactoferrin in vitro on molecular phenotype of human breast cancer cells
by: Chekhun, V.F., et al.
Published: (2015)
by: Chekhun, V.F., et al.
Published: (2015)
Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
by: Chekhun, S.V., et al.
Published: (2014)
by: Chekhun, S.V., et al.
Published: (2014)
Metabolic changes during development of Walker-256 carcinosarcoma resistance to doxorubicin
by: Todor, I.N., et al.
Published: (2015)
by: Todor, I.N., et al.
Published: (2015)
Establishment and characterization of new breast and ovarian cancer cell lines as a model for studying cellular plasticity in vitro
by: Bezdieniezhnykh, N., et al.
Published: (2016)
by: Bezdieniezhnykh, N., et al.
Published: (2016)
СD44+/CD24− markers of cancer stem cells in patients with breast cancer of different molecular subtypes
by: Chekhun, S.V., et al.
Published: (2015)
by: Chekhun, S.V., et al.
Published: (2015)
Are CD44⁺/CD24⁻ cells the assumed cancer stem cells in breast cancer?
by: Ryspayeva, D.E., et al.
Published: (2017)
by: Ryspayeva, D.E., et al.
Published: (2017)
Relation between pathomorphological response in tumors after neoadjuvant chemotherapy and clinico-morphological and molecular prognostic factors in patients with breast cancer
by: Timovska, Yu.O., et al.
Published: (2009)
by: Timovska, Yu.O., et al.
Published: (2009)
Impact of combinations of EGF, TGFβ, 17β-oestradiol, and inhibitors of corresponding pathways on proliferation of breast cancer cell lines
by: Mints, M., et al.
Published: (2014)
by: Mints, M., et al.
Published: (2014)
Growth inhibitory and adjuvant therapeutic potential of aqueous extract of Triticum aestivum on MCF-7 and HeLa cells
by: Hussain, A., et al.
Published: (2014)
by: Hussain, A., et al.
Published: (2014)
Dihydropyrimidine dehydrogenase activity correlates with fluorouracil sensitivity in breast cancer
by: Yu, Z., et al.
Published: (2007)
by: Yu, Z., et al.
Published: (2007)
Aspisol inhibits tumor growth and induces apoptosis in breast cancer
by: Zhu, X.G., et al.
Published: (2008)
by: Zhu, X.G., et al.
Published: (2008)
Genetic polymorphisms of the renin-angiotensin system in breast cancer patients
by: Fishchuk, L.E., et al.
Published: (2013)
by: Fishchuk, L.E., et al.
Published: (2013)
Breast cancer immunohistochemical features in young women with BRCA1/2 mutations
by: Zakhartseva, L.M., et al.
Published: (2009)
by: Zakhartseva, L.M., et al.
Published: (2009)
OX40L gene polymorphism and breast cancer in Iranian population
by: Vakil Monfared, R., et al.
Published: (2018)
by: Vakil Monfared, R., et al.
Published: (2018)
The role of cardiac biomarkers as predictors of trastuzumab cardiotoxicity in patients with breast cancer
by: Ürün, Y., et al.
Published: (2015)
by: Ürün, Y., et al.
Published: (2015)
Influence of exogenous lactoferrin on the oxidant/ antioxidant balance and molecular profile of hormone receptor-positive and -negative human breast cancer cells in vitro
by: Zalutski, I.V., et al.
Published: (2017)
by: Zalutski, I.V., et al.
Published: (2017)
Genotoxic factors associated with the development of receptor-negative breast cancer: potential role of the phenomenon of switching of estrogen effects
by: Berstein, L.M., et al.
Published: (2006)
by: Berstein, L.M., et al.
Published: (2006)
Clinicopathological features of nonspecific invasive breast cancer according to its molecular subtypes
by: Zavyalova, M., et al.
Published: (2016)
by: Zavyalova, M., et al.
Published: (2016)
Experimental study of liposomal docetaxel analysis of docetaxel incorporation and stability
by: Krasnopolsky, Y.M., et al.
Published: (2017)
by: Krasnopolsky, Y.M., et al.
Published: (2017)
Cytogenetic effects of neutron therapy in patients with parotid gland tumors and relapse of breast cancer
by: Melnikov, A.A., et al.
Published: (2012)
by: Melnikov, A.A., et al.
Published: (2012)
Down-regulation of ABCC11 protein (MRP8) in human breast cancer
by: Sosonkina, N., et al.
Published: (2011)
by: Sosonkina, N., et al.
Published: (2011)
Clinical and immunohistochemical features of primary breast cancer and metachronous ovarian and endometrial tumors
by: Kryzhanivska, A.E., et al.
Published: (2018)
by: Kryzhanivska, A.E., et al.
Published: (2018)
Lapatinib-based therapy for women with advanced/metastatic HER2 positive breast cancer
by: Zekri, J., et al.
Published: (2015)
by: Zekri, J., et al.
Published: (2015)
Impact of stromal cell components of tumor microenvironment on epithelial-mesenchymal transition in breast cancer cells
by: Bezdenezhnykh, N., et al.
Published: (2014)
by: Bezdenezhnykh, N., et al.
Published: (2014)
High body-mass index is not associated with worse clinicopathological characteristics in predominantly obese breast cancer patients
by: Kemal, Y., et al.
Published: (2015)
by: Kemal, Y., et al.
Published: (2015)
Possible interference of human beta-herpesviruses-6 and -7 in gastrointestinal cancer development
by: Sultanova A., et al.
Published: (2013)
by: Sultanova A., et al.
Published: (2013)
Influence of doxorubicin inclusion into phospholipid nanoformulation on its antitumor activity in mice: increased efficiency for resistant tumor model
by: Zykova, M.G., et al.
Published: (2012)
by: Zykova, M.G., et al.
Published: (2012)
Molecular-genetic models for prognosis of development of tumors of reproductive system in women with family history of cancer
by: Paliychuk, O.V., et al.
Published: (2018)
by: Paliychuk, O.V., et al.
Published: (2018)
Similar Items
-
Molecular profile and cell cycle in MCF-7 and MCF‑7/Dox cells exposed to conventional and liposomal forms of doxorubicin
by: Rusetskaya, N.V., et al.
Published: (2009) -
The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
by: Todor, I.N., et al.
Published: (2012) -
Molecular profile and cell cycle in mcf-7 cells resistant to cisplatin and doxorubicin
by: Lukyanova, N.Yu., et al.
Published: (2009) -
Correlation of iodine symporter expression in highly and low malignant cell lines of human breast cancer differed in their sensitivity to doxorubicin
by: Lukianova, N.Yu., et al.
Published: (2016) -
Ultrastructural changes in tumor cells treated with liposomal forms of anticancer drugs
by: Yurchenko, O.V., et al.
Published: (2010)